RIMKLA Antikörper (AA 19-391)
Kurzübersicht für RIMKLA Antikörper (AA 19-391) (ABIN7871590)
Target
Alle RIMKLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 19-391
-
Verwendungszweck
- RIMKLA Antibody / NAAG synthetase A
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- E. coli-derived recombinant human protein (amino acids Q19-K391) was used as the immunogen for the RIMKLA antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the RIMKLA antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the RIMKLA antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- RIMKLA (Ribosomal Modification Protein RimK-Like Family Member A (RIMKLA))
-
Andere Bezeichnung
- RIMKLA
-
Hintergrund
- Predicted to enable N-acetyl-L-aspartate-L-glutamate ligase activity. Predicted to be involved in glutamine family amino acid metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.
-
UniProt
- Q8IXN7
Target
-